Last edition
News about Global Pharma
India, Trinidad and Tobago Sign 6 MoUs to Boost Bilateral Cooperation, Including in Pharma
India has signed six Memoranda of Understanding (MoUs) with Trinidad and Tobago to enhance cooperation across several key sectors, including pharmaceuticals.
Global Pharma | 05/07/2025 | By Manvi | 350
Henlius, HanchorBio Partner to Develop HCB101 for Tumour Immunotherapy
Shanghai Henlius Biotech has entered a strategic partnership with HanchorBio’s subsidiary FBD Biologics to license and develop HCB101, a novel SIRPα-Fc fusion protein for tumour immunotherapy, with exclusive rights in China, Southeast Asia, and MENA.
Global Pharma | 05/07/2025 | By Mrinmoy Dey | 313
Lupin has launched its Ipratropium Bromide Nasal Solution, 0.03 percent and 0.06 percent, in the US market, offering bioequivalent alternatives to Atrovent Nasal Spray for the treatment of rhinorrhea.
Global Pharma | 04/07/2025 | By Mrinmoy Dey | 449
Sunshine Biopharma Enters Canadian Biosimilars Market with Launch of Niopeg
Niopeg is a biosimilar to Neulasta (Pegfilgrastim), a long-acting, pegylated form of recombinant human granulocyte colony-stimulating factor (filgrastim), used to reduce infection risk in cancer patients undergoing chemotherapy.
Global Pharma | 04/07/2025 | By Darshana | 280
Lincoln Pharma's New Khatraj Facility Completes Trial Run
Lincoln Pharmaceuticals Ltd has completed the trial run at its newly built manufacturing facility located at Trimul Estate in Khatraj, Gujarat.
Global Pharma | 04/07/2025 | By Manvi | 530
India, Myanmar Explore Fast-Track Pharma Approvals; MoU Likely at iPHEX 2025
India is currently a major supplier of medicines to Myanmar, meeting nearly 60% of the country’s pharmaceutical needs. The MoU will aim to expand bilateral cooperation in pharma trade and regulatory alignment.
Global Pharma | 04/07/2025 | By Darshana | 192
Alembic Pharma Acquires American Utility Therapeutics for USD 12 Million
Alembic Pharmaceuticals Inc., a wholly owned subsidiary of Alembic Pharmaceuticals Ltd., has acquired American Utility Therapeutics for USD 12 million (over INR 100 crore), strengthening its presence in the US market.
Global Pharma | 03/07/2025 | By Manvi | 264
Merck recently reported a 17% decline in sales of its HPV vaccine Gardasil in China, citing increasing price pressure from domestic manufacturers and the impact of China’s ongoing anti-corruption drive in the healthcare industry.
Global Pharma | 03/07/2025 | By Darshana | 445
Biocon Biologics Receives European Commission Nod for Denosumab Biosimilars to Improve Bone Health
Biocon Biologics has received European Commission approval for its Denosumab biosimilars, Vevzuo and Evfraxy, thereby expanding access to advanced treatments for bone-related conditions across the EU.
Global Pharma | 03/07/2025 | By Mrinmoy Dey | 265
Lupin Spins Off Consumer Healthcare Arm into New Subsidiary, Appoints New CEO
Lupin noted that the move aligns with their broader strategy to establish a specialised consumer healthcare entity, with an enhanced focus on India’s rapidly growing self-care market.
Global Pharma | 02/07/2025 | By Manvi | 437
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy